Last updated on July 2020

Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis


Brief description of study

Safety and efficacy of nemolizumab in subjects with moderate-to-severe atopic dermatitis

Detailed Study Description

Assess the safety and efficacy of nemolizumab in subjects with moderate-to-severe AD

Clinical Study Identifier: NCT03985943

Find a site near you

Start Over

Galderma Investigational Site

Little Rock, AR United States
4.63miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.